| Lung Cancer |
1 |
1 |
| Genomic Medicine |
0 |
0.9 |
| Non-Small Cell Lung Cancer |
0 |
0.99 |
| Epidermal Growth Factor Receptor |
0 |
0.98 |
| Biologic Therapy |
0 |
0.43 |
| Small Cell Lung Cancer |
0 |
0.42 |
| Cancer |
0 |
0.34 |
| Food and Drug Administration (FDA) |
0 |
0.97 |
| Dentistry and Oral Health |
0 |
0.32 |
| Toxicology |
0 |
0.32 |
| Lung |
0 |
0.26 |
| Tyrosine Kinase Inhibitor |
0 |
0.96 |
| Interstitial Lung Disease |
0 |
0.21 |
| Pain Management |
0 |
0.14 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.13 |
| DNA Sequencing |
0 |
0.13 |
| HIV Infection |
0 |
0.13 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.13 |
| Tyrosine Kinase |
0 |
0.13 |
| Diarrhea |
0 |
0.09 |
| Grant |
0 |
0.09 |
| Platinum |
0 |
0.09 |
| Polymerase Chain Reaction |
0 |
0.09 |
| Chemotherapy |
0 |
0.04 |
| Emesis |
0 |
0.04 |
| Fatigue |
0 |
0.04 |
| Nausea |
0 |
0.04 |
| Orphan Drugs |
0 |
0.04 |
| Pain |
0 |
0.04 |
| Paronychia |
0 |
0.04 |
| Receptors |
0 |
0.04 |
| Skin and Soft Tissue Infection |
0 |
0.04 |
| Stomatitis |
0 |
0.04 |
| Xeroderma |
0 |
0.04 |